Literature DB >> 8574806

Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein.

J R Ballinger1, K M Sheldon, I Boxen, C Erlichman, V Ling.   

Abstract

Both 99mTc-MIBI and 201Tl have been used for tumour imaging. It has recently been reported that 99mTc-MIBI is a substrate for P-glycoprotein (Pgp), a membrane pump which mediates multidrug resistance. We have evaluated the role of Pgp in the cellular accumulation of 201Tl by using sensitive and resistant strains of Chinese hamster ovary (CHO) fibroblasts (AuxB1 and CHRC5, respectively) grown in suspension culture. 201Tl accumulation was the same in sensitive and resistant cells, whereas 99mTc-MIBI accumulation was much lower in resistant cells than in sensitive ones. Down-modulation of Pgp with 100 microM verapamil did not alter cellular accumulation of 201Tl while it significantly increased 99mTc-MIBI accumulation in both types of cell. Similarly, 10 microM verapamil did not affect the rate of washout of 201Tl from preloaded cells, while 99mTc-MIBI washout was greatly reduced in the presence of verapamil. These results suggest that 201Tl will accumulate in both sensitive and resistant tumour cells, whereas 99mTc-MIBI will be extruded from resistant cells and therefore may be less useful for tumour detection when the tumour cells express high Pgp levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574806

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN: 1125-0135


  5 in total

1.  Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.

Authors:  Amr Amin; Hosna Moustafa; Ebaa Ahmed; Mohamed El-Toukhy
Journal:  J Neurooncol       Date:  2011-09-13       Impact factor: 4.130

2.  P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.

Authors:  Yigit S Guner; Ashanti L Franklin; Nikunj K Chokshi; Shannon L Castle; Elizabeth Pontarelli; Jin Wang; Larry Wang; Nemani V Prasadarao; Jeffrey S Upperman; Anatoly V Grishin; Henri R Ford
Journal:  Lab Invest       Date:  2011-07-25       Impact factor: 5.662

Review 3.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

Review 4.  Imaging of multidrug resistance in cancer.

Authors:  S Dizdarevic; A M Peters
Journal:  Cancer Imaging       Date:  2011-03-01       Impact factor: 3.909

5.  Effectiveness of Tc-99m MIBI scintigraphy in diagnosing lung cancer.

Authors:  S Tanaka; T Asao; M Ubukata; H Sugiyama; Y Yajima; S Takenoshita; Y Nagamachi
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.